MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$3,987K
Free Cash flow
-$83,340K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities and sal...
Impairment and disposal of long-...
Net income (loss)
Others
Negative Cash Flow Breakdown
Deferred revenue
Lease liabilities, net
Accrued liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Stock-based compensation expense
8,200
Other
0
Net income (loss)
44,692
Prepaid expenses and other current assets
-5,915
Other non-current liabilities
-366
Other non-current assets
-244
Lease liabilities, net
-32,654
Deferred revenue
-144,122
Accrued liabilities
-23,221
Accounts payable
1,445
Depreciation
2,713
Net accretion of discounts on marketable securities
1,254
Termination of prepaid contracts and other costs
915
Purchase of net (premiums) discounts on marketable securities
307
Non-cash lease expense
1,603
Impairment and disposal of long-lived assets
52,889
Net cash used in operating activities
-83,308
Proceeds from sales of property, plant and equipment
2,372
Proceeds from maturities and sales of marketable securities
101,122
Purchase of property, plant and equipment
32
Purchases of marketable securities
16,184
Net cash provided by investing activities
87,278
Proceeds from purchases under the employee stock purchase plan
4
Proceeds from exercise of stock options
13
Payment of employee taxes and exercise costs for shares withheld
0
Payment of deferred offering costs
0
Net cash provided by financing activities
17
Net increase (decrease) in cash, cash equivalents, and restricted cash
3,987
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
and sales of...
$101,122K
Proceeds from exercise of
stock options
$13K
Proceeds from purchases
under the employee...
$4K
Proceeds from sales of
property, plant and...
$2,372K
Net cash provided by
investing activities
$87,278K
Net cash provided by
financing activities
$17K
Canceled cashflow
$16,216K
Net increase
(decrease) in cash, cash...
$3,987K
Canceled cashflow
$83,308K
Purchases of marketable
securities
$16,184K
Purchase of property,
plant and equipment
$32K
Impairment and disposal of
long-lived assets
$52,889K
Net income (loss)
$44,692K
Stock-based compensation
expense
$8,200K
Prepaid expenses and
other current assets
-$5,915K
Depreciation
$2,713K
Non-cash lease expense
$1,603K
Accounts payable
$1,445K
Termination of prepaid
contracts and other costs
$915K
Other non-current
assets
-$244K
Net cash used in
operating activities
-$83,308K
Canceled cashflow
$118,616K
Deferred revenue
-$144,122K
Lease liabilities,
net
-$32,654K
Accrued liabilities
-$23,221K
Net accretion of
discounts on marketable...
$1,254K
Other non-current
liabilities
-$366K
Purchase of net
(premiums) discounts on...
$307K
Buy us a coffee
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)